...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy
【24h】

Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy

机译:基于核心针活检的组织病理学特征和钙化评价的乳房非典型导管增生诊断升级

获取原文
获取原文并翻译 | 示例

摘要

Aims Atypical ductal hyperplasia (ADH) of breast is increasingly diagnosed in core needle biopsy (CNB). As higher‐grade lesions were found in the excision in a substantial proportion of ADH on CNB, factors predicting risk of subsequent upgrade are clinically significant. This study aims to investigate relevant histopathological factors in CNB that could predict diagnostic upgrade at excision. Methods and results One hundred and forty‐three cases of CNB with paired subsequent excision were evaluated for multiple clinicopathological parameters related to CNB sampling, ADH morphology, calcification and other co‐existing histological features, and which of these parameters were associated with diagnostic upgrade at subsequent excisions were determined. Forty‐eight cases (34.3%) were upgraded to malignancy, including 15 invasive cancers and 33 ductal carcinomas in situ (DCIS). An increased tissue area occupied by ADH ( P ?=?0.026), a higher number of ADH foci ( P ?=?0.004), the presence of solid pattern ( P ?=?0.037) and older age ( P ?=?0.012) were positively associated with upgrade, while negative associations were found with the presence of micropapillary pattern ( P ?=?0.025), co‐existing columnar cell lesions (CCL) ( P ?=?0.001) and the presence of calcifications ( P ?=?0.009). Multivariate logistic regression analysis showed that the number of ADH foci (HR?=?2.810, P ?=?0.013) was an independent positive predictor, while co‐existing CCL (HR?=?0.391, P ?=?0.013) was an independent negative predictor for upgrade. Conclusions Patients with ADH in CNB showing the presence of co‐existing CCL and a lower number of ADH foci have a lower risk of disease upgrade at excision, and are potential candidates for observation‐only management.
机译:目的在核心针活检(CNB)中,乳房的非典型导管增生(ADH)越来越诊断。随着在CNB上的大部分ADH的大部分ADH中发现较高级病变,预测随后升级风险的因素是临床显着性。本研究旨在调查CNB中的相关组织病理因素,可以预测切除诊断升级。对CNB采样,ADH形态,钙化和其他共存组织学特征的多个临床病理学参数评估了与成对后续切除的二十三种CNB的CNB的方法和结果评估了多种临床病理学参数,以及这些参数中的哪一个与诊断升级有关确定后续的自信。 48例(34.3%)升级为恶性肿瘤,包括15名侵入性癌症和原位(DCIS)的侵袭性癌症。由ADH占据的组织面积增加(P?= 0.026),较高数量的ADH焦点(P?= 0.004),固体图案的存在(p?= 0.037)和较大的年龄(p?= 0.012 )与升级有阳性相关,而在存在微杂种图案(P?= 0.025)的情况下发现阴性关联,共同现有的柱状细胞病变(CCl)(p?= 0.001)和钙化的存在(P? = 0.009)。多变量逻辑回归分析表明,ADH焦点的数量(HR?=?2.810,P?0.013)是一个独立的阳性预测因子,而共同现有的CCL(HR?= 0.391,P?= 0.013)是一种升级的独立负预测器。结论CNB中ADH患者显示共存CCL的存在和较低数量的ADH焦点在切除时患疾病升级的风险较低,并且是仅观察管理的潜在候选人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号